EMA warns of increased risk for pulmonary embolism and death with higher dose of tofacitinib - medwireNews

EMA warns of increased risk for pulmonary embolism and death with higher dose of tofacitinib  medwireNews

medwireNews: The EMA has issued a safety alert warning that the recommended 5 mg twice daily dose of the Janus kinase inhibitor tofacitinib should not be ...